{"schema_version":"alpha-profile-public-v1","slug":"james-peyer","canonical_url":"https://registry.alpha.ac/people/james-peyer","as_of":"2026-10-06T07:53:49.693658+00:00","published_at":"2026-09-02T02:37:24.802336+00:00","last_reviewed_at":"2026-05-16T02:39:52.583+00:00","identity":{"display_name":"James Peyer","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Faeth Therapeutics, Inc.","company_slug":"faeth-therapeutics-inc","exchange":"NASDAQ","ticker":"FTH","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2020-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1829802/000095017025053033/snse-def-proxy-fy2024_no.htm","effective_date":"2025-04-11","last_checked_at":"2026-04-28T23:56:01.279+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=james-peyer","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=james-peyer&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["James Peyer, Ph.D. has served on Sensei Biotherapeutics' Board since January 2020. He founded and serves as CEO of Cambrian Biopharma in 2019 and previously founded Cleara Biotech and Apollo Health Ventures. He holds a B.A. in Biology from University of Chicago and a Ph.D. in Stem Cell Biology from UT Southwestern."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Faeth Therapeutics, Inc.","organizationId":"faeth-therapeutics-inc","title":"Director","period":"2020-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1829802/000095017025053033/snse-def-proxy-fy2024_no.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Faeth Therapeutics, Inc.","company_slug":"faeth-therapeutics-inc","exchange":"NASDAQ","ticker":"FTH","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2020-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1829802/000095017025053033/snse-def-proxy-fy2024_no.htm","effective_date":"2025-04-11","last_checked_at":"2026-04-28T23:56:01.279+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for James Peyer as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:39:52.732264+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SNSE DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1829802/000095017025053033/snse-def-proxy-fy2024_no.htm","published_at":"2025-04-11T00:00:00+00:00","last_checked_at":"2026-05-16T02:39:52.636412+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"James Peyer currently serves as Director at Sensei Biotherapeutics, Inc..","claim_state":"verified","valid_from":"2025-04-11","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:39:52.699346+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SNSE DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1829802/000095017025053033/snse-def-proxy-fy2024_no.htm","published_at":"2025-04-11T00:00:00+00:00","last_checked_at":"2026-05-16T02:39:52.636412+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Compensation","Nominating/Governance"],"claim_text":"James Peyer serves on Compensation, Nominating/Governance.","claim_state":"verified","valid_from":"2025-04-11","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:39:52.716406+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SNSE DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1829802/000095017025053033/snse-def-proxy-fy2024_no.htm","published_at":"2025-04-11T00:00:00+00:00","last_checked_at":"2026-05-16T02:39:52.636412+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Cambrian Biopharma","claim_text":"James Peyer is linked to Cambrian Biopharma as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:39:52.829555+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SNSE DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1829802/000095017025053033/snse-def-proxy-fy2024_no.htm","published_at":"2025-04-11T00:00:00+00:00","last_checked_at":"2026-05-16T02:39:52.636412+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Chief Executive Officer","claim_text":"James Peyer is also listed as Chief Executive Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:39:52.814337+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SNSE DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1829802/000095017025053033/snse-def-proxy-fy2024_no.htm","published_at":"2025-04-11T00:00:00+00:00","last_checked_at":"2026-05-16T02:39:52.636412+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for James Peyer as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:39:52.765305+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SNSE DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1829802/000095017025053033/snse-def-proxy-fy2024_no.htm","published_at":"2025-04-11T00:00:00+00:00","last_checked_at":"2026-05-16T02:39:52.636412+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for James Peyer as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:39:52.748948+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SNSE DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1829802/000095017025053033/snse-def-proxy-fy2024_no.htm","published_at":"2025-04-11T00:00:00+00:00","last_checked_at":"2026-05-16T02:39:52.636412+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:james-peyer","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2020-01-01 · current","organization":"Faeth Therapeutics, Inc.","organization_id":"faeth-therapeutics-inc"},"claim_text":"Director at Faeth Therapeutics, Inc. (2020-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1829802/000095017025053033/snse-def-proxy-fy2024_no.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/james-peyer#profile","url":"https://registry.alpha.ac/people/james-peyer","dateModified":"2026-05-16T02:39:52.583+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/james-peyer#person","name":"James Peyer","url":"https://registry.alpha.ac/people/james-peyer","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Faeth Therapeutics, Inc.","tickerSymbol":"NASDAQ: FTH"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2020-01-01","memberOf":{"@type":"Organization","name":"Faeth Therapeutics, Inc.","url":"https://registry.alpha.ac/companies/faeth-therapeutics-inc","tickerSymbol":"NASDAQ: FTH"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1829802/000095017025053033/snse-def-proxy-fy2024_no.htm","name":"SNSE DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/james-peyer"},"registry_intelligence":{"schema_version":"alpha-registry-intelligence-v1","record_version":"d751713988987e9331980363e24189ce","subject":"alpha:person:james-peyer","as_of":"2026-10-06T07:53:50.127751+00:00","recorded_at":"2026-10-06T07:53:50.127751+00:00","availability":"available","records":[],"next_offset":null,"limitations":["Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage."]},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-16T02:39:52.583+00:00","observed_at":"2026-10-06T07:53:49.693658+00:00","freshness_days":143}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"james-peyer","canonical_url":"https://registry.alpha.ac/people/james-peyer"},"publication":{"published_at":"2026-09-02T02:37:24.802336+00:00","last_reviewed_at":"2026-05-16T02:39:52.583+00:00","as_of":"2026-10-06T07:53:49.693658+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/james-peyer","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/james-peyer","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/james-peyer.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}